Analyst ratings are influencing stock price targets for Sanofi and Deutsche Bank.
1 report, 1 independent
Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst ratings are influencing stock price targets for Sanofi and Deutsche Bank.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Sanofi
company in Milan, Italy
Nothing else this week.
-
Deutsche Bank
German global banking and financial services company
Related events
- Analyst targets are being revised to reflect market concerns regarding future earnings and fuel cost volatility for companies including Goldman Sachs, Carnival Corp., and Deutsche Bank.
- Spyre Therapeutics, Inc. was listed on Nasdaq and received analyst ratings from firms including Deutsche Bank and Stifel.
- Deutsche Bank reiterated a buy rating and price objective, while Citigroup and Jefferies Financial Group issued buy ratings and price targets for an unnamed company.
- Deutsche Bank restated a buy rating on Performance Food Group Company on August 25, 2026.
- Both HSBC and Deutsche Bank provided market analysis and commentary on September 1, 2026.